Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Frontiers in Psychiatry
|
December 19, 2022
Lower-dose psycholytic therapy - A neglected approach
Torsten Passie, Jeffrey Guss, Rainer Krähenmann
Frontiers in Psychiatry
|
December 23, 2024
Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use
Jonathan Brett, Elizabeth Knock, Kathy Watson, et al.
Psychodynamic Psychiatry
|
June 16, 2026
Psychodynamic Perspectives on Psychedelic States and Treatment Contexts: A Conceptual and Clinical Introduction
Nadav Liam Modlin, Zsofia Elek, Carolina Maggio, et al.
Scientific Reports
|
April 17, 2024
Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial
Jordan Sloshower, Richard J Zeifman, Jeffrey Guss, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 10, 2020
Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer
Gabrielle I Agin-Liebes, Tara Malone, Matthew M Yalch, et al.
ACS Pharmacology & Translational Science
|
April 16, 2021
Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer
Stephen Ross, Gabrielle Agin-Liebes, Sharon Lo, et al.
Frontiers in Pharmacology
|
April 19, 2018
Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy
Tara C Malone, Sarah E Mennenga, Jeffrey Guss, et al.
Journal of Psychopharmacology (Oxford, England)
|
December 3, 2016
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Stephen Ross, Anthony Bossis, Jeffrey Guss, et al.
Frontiers in Pain Research (Lausanne, Switzerland)
|
April 2, 2025
Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: an open-label pilot clinical trial
Jacob S Aday, Jenna McAfee, Deirdre A Conroy, et al.
Journal of Psychopharmacology (Oxford, England)
|
June 10, 2025
A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapy
Torsten Passie, Anja Loizaga-Velder, Alicia Danforth, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Frontiers in Psychiatry
|
December 19, 2022
Lower-dose psycholytic therapy - A neglected approach
Torsten Passie, Jeffrey Guss, Rainer Krähenmann
Frontiers in Psychiatry
|
December 23, 2024
Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use
Jonathan Brett, Elizabeth Knock, Kathy Watson, et al.
Psychodynamic Psychiatry
|
June 16, 2026
Psychodynamic Perspectives on Psychedelic States and Treatment Contexts: A Conceptual and Clinical Introduction
Nadav Liam Modlin, Zsofia Elek, Carolina Maggio, et al.
Scientific Reports
|
April 17, 2024
Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial
Jordan Sloshower, Richard J Zeifman, Jeffrey Guss, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 10, 2020
Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer
Gabrielle I Agin-Liebes, Tara Malone, Matthew M Yalch, et al.
ACS Pharmacology & Translational Science
|
April 16, 2021
Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer
Stephen Ross, Gabrielle Agin-Liebes, Sharon Lo, et al.
Frontiers in Pharmacology
|
April 19, 2018
Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy
Tara C Malone, Sarah E Mennenga, Jeffrey Guss, et al.
Journal of Psychopharmacology (Oxford, England)
|
December 3, 2016
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Stephen Ross, Anthony Bossis, Jeffrey Guss, et al.
Frontiers in Pain Research (Lausanne, Switzerland)
|
April 2, 2025
Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: an open-label pilot clinical trial
Jacob S Aday, Jenna McAfee, Deirdre A Conroy, et al.
Journal of Psychopharmacology (Oxford, England)
|
June 10, 2025
A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapy
Torsten Passie, Anja Loizaga-Velder, Alicia Danforth, et al.
Page
of 2